Hospira Names Francois L. Dubois Senior Vice President of Quality

LAKE FOREST, Ill., Nov. 22, 2010 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, announced today that Francois (Frans) L. Dubois has been named to the newly created position of senior vice president, Quality, effective Jan. 3, 2011. In this capacity, he will have overall responsibility for Hospira's global quality systems and serve as a member of Hospira's senior leadership team. He will report directly to Christopher Begley, chairman and chief executive officer.

"Frans is a seasoned leader with more than 30 years of diverse quality experience spanning large global companies and smaller healthcare firms, and cross-sector expertise including pharmaceuticals, biotechnology and medical devices," said Begley. "With his proven track record in working with regulatory bodies around the world and implementing robust global quality systems, Frans' appointment reinforces Hospira's commitment to establishing quality as a strategic, competitive advantage across our global operations. We are excited to have him lead the continued transformation of our patient-focused quality organization."

Under Dubois' leadership, Hospira will advance its global quality and compliance strategies, drive the continuous improvement of established quality procedures to ensure that processes and products meet high internal standards and regulatory requirements, and ultimately deliver high-quality, cost-effective products to customers.

Previously, Dubois, 57, served as vice president of quality for Tengion, Inc., where he was responsible for the biotechnology company's quality and compliance operations. Prior to joining Tengion, he spent more than 10 years at Johnson & Johnson in increasing roles of responsibility, most recently as vice president, Global External Manufacturing and Supplier Quality Operations. In this position, Dubois was responsible for driving transformation of the supply chain through quality operations at external sites, including pharmaceutical suppliers and bulk active pharmaceutical ingredient (API) and biologics manufacturing.

During his career, Dubois served in numerous quality and operations roles and has also worked as a business consultant to several pharmaceutical companies. He earned his master's degree in pharmacy from Leiden University, the Netherlands.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing WellnessTM. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 13,500 employees. Learn more at www.hospira.com.

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.